Literature DB >> 18661550

Frequency of social phobia and psychometric properties of the Liebowitz social anxiety scale in Parkinson's disease.

Arthur Kummer1, Francisco Cardoso, Antonio L Teixeira.   

Abstract

There are few studies about social anxiety disorder in Parkinson's disease (PD). The objective of this study was to assess its frequency and to explore the psychometric properties of the Liebowitz social anxiety scale (LSAS) in PD. Ninety patients with PD underwent neurologic and psychiatric examination. Psychiatric examination was composed by a structured clinical interview (MINI-Plus) followed by the application of the LSAS, the Hamilton depression rating scale (Ham-D), and the Hamilton anxiety rating scale (Ham-A). Neurologic examination included the MMSE, the UPDRS, the Hoehn-Yahr Scale, and the Schwab-England scale of activities of daily living. Social phobia was diagnosed in 50% of PD patients. The disorder was not associated with any sociodemographic or neurological feature, but was associated to major depression (P = 0.023), generalized anxiety disorder (P = 0.023), and obsessive-compulsive disorder (P = 0.013). The score of LSAS correlated positively with the scores of Ham-D and Ham-A (P < 0.001 for both). A ROC curve analysis of the LSAS suggested that a cutoff score in 41/42 provided the best balance between sensitivity and specificity. This disorder seems to be more common and not just restricted to performance as previously thought. (c) 2007 Movement Disorder Society.

Entities:  

Mesh:

Year:  2008        PMID: 18661550     DOI: 10.1002/mds.22221

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  15 in total

1.  Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease.

Authors:  Gregory M Pontone; James R Williams; Karen E Anderson; Gary Chase; Susanne A Goldstein; Stephen Grill; Elaina S Hirsch; Susan Lehmann; John T Little; Russell L Margolis; Peter V Rabins; Howard D Weiss; Laura Marsh
Journal:  Mov Disord       Date:  2009-07-15       Impact factor: 10.338

Review 2.  Parkinson's disease: the quintessential neuropsychiatric disorder.

Authors:  Daniel Weintraub; David J Burn
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

3.  Motion and emotion: anxiety-axial connections in Parkinson's disease.

Authors:  Rastislav Šumec; Irena Rektorová; Robert Jech; Kateřina Menšíková; Jan Roth; Evžen Růžička; Dana Sochorová; Ladislav Dušek; Petr Kaňovský; Ivan Rektor; Tomáš Pavlík; Pavel Filip; Martin Bareš
Journal:  J Neural Transm (Vienna)       Date:  2016-11-23       Impact factor: 3.575

4.  Promoting exercise in Parkinson's disease through community-based participatory research.

Authors:  Mark A Hirsch; Sanjay S Iyer; Danielle Englert; Mohammed Sanjak
Journal:  Neurodegener Dis Manag       Date:  2011-10

Review 5.  The Neuropsychiatry of Parkinson Disease: A Perfect Storm.

Authors:  Daniel Weintraub; Eugenia Mamikonyan
Journal:  Am J Geriatr Psychiatry       Date:  2019-03-09       Impact factor: 4.105

6.  Use of the World Health Organization Quality of Life Assessment Short Version in Mild to Moderate Parkinson Disease.

Authors:  Sarah K Hendred; Erin R Foster
Journal:  Arch Phys Med Rehabil       Date:  2016-06-23       Impact factor: 3.966

Review 7.  Management of psychiatric disorders in Parkinson's disease : Neurotherapeutics - Movement Disorders Therapeutics.

Authors:  Daniel Weintraub
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

8.  Epigenome-wide association study for Parkinson's disease.

Authors:  Kerry Moore; Amy Jayne McKnight; David Craig; Francis O'Neill
Journal:  Neuromolecular Med       Date:  2014-10-11       Impact factor: 3.843

9.  Psychiatric disorders in primary focal dystonia and in Parkinson's disease.

Authors:  Fernando Mv Dias; Arthur Kummer; Flávia Cp Doyle; Estefânia Harsányi; Francisco Cardoso; Leonardo F Fontenelle; Antônio Lúcio Teixeira
Journal:  Neuropsychiatr Dis Treat       Date:  2011-03-14       Impact factor: 2.570

10.  Beta receptor-mediated modulation of the late positive potential in humans.

Authors:  Mischa de Rover; Stephen B R E Brown; Nathalie Boot; Greg Hajcak; Martijn S van Noorden; Nic J A van der Wee; Sander Nieuwenhuis
Journal:  Psychopharmacology (Berl)       Date:  2011-08-17       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.